Upgrade to SI Premium - Free Trial

Illumina (ILMN)

190.87 -1.66 (0.86%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)
- M&A (6/30/19 *Est)

Latest Headlines

Illumina expands Billion Cell Atlas program with new AI drug developers July 16, 2026 12:00 PM - PR NewsWire Illumina (ILMN) PT Raised to $190 at Canaccord July 14, 2026 6:42 AM - StreetInsider Illumina (ILMN) PT Raised to $208 at Baird July 13, 2026 7:18 AM - StreetInsider Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026 July 9, 2026 4:05 PM - PR NewsWire Illumina names new chief commercial and chief legal officers July 9, 2026 9:05 AM - StreetInsider Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer July 9, 2026 9:05 AM - PR NewsWire Form 4 ILLUMINA, INC. For: Jun 30 Filed by: Meister Keith A. July 2, 2026 6:26 PM - SEC Filing Form 4 ILLUMINA, INC. For: Jun 30 Filed by: Ullem Scott B. July 2, 2026 6:22 PM - SEC Filing Illumina (ILMN) PT Raised to $200 at Piper Sandler July 1, 2026 6:40 AM - StreetInsider Illumina (ILMN) PT Raised to $200 at Guggenheim June 29, 2026 6:55 AM - StreetInsider Bernstein SocGen Group Resumes Illumina (ILMN) at Market Perform June 26, 2026 6:07 AM - StreetInsider Form 4 ILLUMINA, INC. For: Jun 25 Filed by: Davies Scott M June 25, 2026 9:42 PM - SEC Filing Form 144 ILLUMINA, INC. Filed by: Davies Scott M June 25, 2026 4:27 PM - SEC Filing Form 144 ILLUMINA, INC. Filed by: ARNOLD FRANCES June 25, 2026 4:05 PM - SEC Filing Illumina (ILMN) PT Raised to $145 at Barclays June 24, 2026 2:59 AM - StreetInsider Form 4 ILLUMINA, INC. For: Jun 16 Filed by: Skovronsky Daniel June 23, 2026 6:01 PM - SEC Filing Form 3 ILLUMINA, INC. For: Jun 16 Filed by: Skovronsky Daniel June 23, 2026 5:57 PM - SEC Filing Form 8-K ILLUMINA, INC. For: Jun 16 June 23, 2026 9:09 AM - SEC Filing Illumina adds Eli Lilly's chief scientific officer to its board June 23, 2026 9:05 AM - StreetInsider Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors June 23, 2026 9:05 AM - PR NewsWire IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist June 19, 2026 3:00 AM - BizWire Illumina upgraded to overweight at JPMorgan on clinical demand outlook June 10, 2026 3:50 PM - StreetInsider JPMorgan Upgrades Illumina (ILMN) to Overweight June 10, 2026 5:49 AM - StreetInsider Form 4 ILLUMINA, INC. For: Jun 05 Filed by: Leckman Patricia June 9, 2026 4:33 PM - SEC Filing Illumina launches StrataMap spatial research solution June 8, 2026 9:15 AM - StreetInsider Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution June 8, 2026 9:15 AM - PR NewsWire Form 144 ILLUMINA, INC. Filed by: Leckman Patricia June 5, 2026 4:04 PM - SEC Filing Form 4 ILLUMINA, INC. For: Jun 02 Filed by: Leckman Patricia June 4, 2026 4:11 PM - SEC Filing Form 144 ILLUMINA, INC. Filed by: ARNOLD FRANCES June 2, 2026 4:37 PM - SEC Filing Form 144 ILLUMINA, INC. Filed by: Leckman Patricia June 2, 2026 4:21 PM - SEC Filing Form 4 ILLUMINA, INC. For: May 28 Filed by: Meister Keith A. June 1, 2026 6:04 PM - SEC Filing Form 4 ILLUMINA, INC. For: May 29 Filed by: Davies Scott M June 1, 2026 4:32 PM - SEC Filing Form 4 ILLUMINA, INC. For: May 28 Filed by: Ericksen Scott D June 1, 2026 4:27 PM - SEC Filing IDT partners with Illumina for oncology research workflows June 1, 2026 8:59 AM - StreetInsider Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights June 1, 2026 8:58 AM - BizWire Illumina (ILMN) PT Raised to $180 at Guggenheim June 1, 2026 7:20 AM - StreetInsider Form 144 ILLUMINA, INC. Filed by: Corvex Management LP May 29, 2026 6:14 PM - SEC Filing Form 144 ILLUMINA, INC. Filed by: Ericksen Scott D May 29, 2026 4:24 PM - SEC Filing Form 144 ILLUMINA, INC. Filed by: Davies Scott M May 29, 2026 4:24 PM - SEC Filing Form 4/A ILLUMINA, INC. For: May 21 Filed by: Meister Keith A. May 29, 2026 4:09 PM - SEC Filing Form 144 ILLUMINA, INC. Filed by: Ericksen Scott D May 28, 2026 5:13 PM - SEC Filing Form 144 ILLUMINA, INC. Filed by: ARNOLD FRANCES May 28, 2026 4:53 PM - SEC Filing Illumina partners with SPT Labtech to launch fireflyGO automation platform May 28, 2026 12:45 PM - StreetInsider Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research May 28, 2026 12:30 PM - PR NewsWire Illumina launches whole-genome sequencing kit for cancer research May 28, 2026 9:16 AM - StreetInsider Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research May 28, 2026 9:15 AM - PR NewsWire Form 8-K ILLUMINA, INC. For: May 21 May 26, 2026 5:28 PM - SEC Filing Form 4 ILLUMINA, INC. For: May 21 Filed by: KING DAVID P May 22, 2026 5:19 PM - SEC Filing Form 4 ILLUMINA, INC. For: May 21 Filed by: SIEGEL SUSAN E May 22, 2026 5:16 PM - SEC Filing Form 4 ILLUMINA, INC. For: May 21 Filed by: Ullem Scott B. May 22, 2026 5:15 PM - SEC Filing Form 4 ILLUMINA, INC. For: May 21 Filed by: SCHILLER PHILIP W May 22, 2026 5:13 PM - SEC Filing Form 4 ILLUMINA, INC. For: May 21 Filed by: RICHO ANNA May 22, 2026 5:12 PM - SEC Filing Form 4 ILLUMINA, INC. For: May 21 Filed by: Meister Keith A. May 22, 2026 5:11 PM - SEC Filing Form 4 ILLUMINA, INC. For: May 21 Filed by: Gottlieb Scott May 22, 2026 5:10 PM - SEC Filing Form 4 ILLUMINA, INC. For: May 20 Filed by: DORSA CAROLINE May 22, 2026 5:09 PM - SEC Filing Form 3 ILLUMINA, INC. For: May 21 Filed by: KING DAVID P May 22, 2026 5:07 PM - SEC Filing ILLUMINA elects former Labcorp CEO David King to board of directors May 21, 2026 4:15 PM - StreetInsider David P. King elected to Illumina's Board of Directors May 21, 2026 4:15 PM - PR NewsWire Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact May 19, 2026 4:30 PM - PR NewsWire Form SD ILLUMINA, INC. May 19, 2026 4:17 PM - SEC Filing Form 4 ILLUMINA, INC. For: May 12 Filed by: Meister Keith A. May 14, 2026 7:22 PM - SEC Filing RBC Capital Assumes Illumina (ILMN) at Outperform May 14, 2026 4:12 PM - StreetInsider Form SCHEDULE 13G/A ILLUMINA, INC. Filed by: Capital World Investors May 14, 2026 1:56 PM - SEC Filing Daiwa Securities Upgrades Illumina (ILMN) to Outperform (2) May 14, 2026 3:24 AM - StreetInsider Form 144 ILLUMINA, INC. Filed by: Corvex Management LP May 13, 2026 5:37 PM - SEC Filing Form 4 ILLUMINA, INC. For: May 07 Filed by: Meister Keith A. May 11, 2026 7:34 PM - SEC Filing Form 4 ILLUMINA, INC. For: May 05 Filed by: Wedel Christensen Jakob May 7, 2026 6:20 PM - SEC Filing Form 144 ILLUMINA, INC. Filed by: Wedel Christensen Jakob May 6, 2026 4:11 PM - SEC Filing Form 10-Q ILLUMINA, INC. For: Mar 29 May 4, 2026 6:02 AM - SEC Filing Illumina (ILMN) PT Raised to $100 at BofA Securities May 1, 2026 10:41 AM - StreetInsider Illumina (ILMN) PT Raised to $125 at JPMorgan May 1, 2026 8:10 AM - StreetInsider Illumina (ILMN) PT Lowered to $140 at Canaccord May 1, 2026 6:39 AM - StreetInsider Illumina (ILMN) PT Raised to $155 at Evercore ISI May 1, 2026 4:14 AM - StreetInsider Illumina (ILMN) PT Raised to $122 at Barclays May 1, 2026 2:46 AM - StreetInsider Illumina (ILMN) Tops Q1 EPS by 9c; offers guidance April 30, 2026 4:15 PM - StreetInsider Form 8-K ILLUMINA, INC. For: Apr 30 April 30, 2026 4:14 PM - SEC Filing Illumina Reports Financial Results for First Quarter of Fiscal Year 2026 April 30, 2026 4:05 PM - PR NewsWire Form SCHEDULE 13G ILLUMINA, INC. Filed by: VANGUARD CAPITAL MANAGEMENT LLC April 30, 2026 10:38 AM - SEC Filing Barclays: Life science insiders sold $187M in stock during first quarter April 28, 2026 9:18 AM - StreetInsider Full Article List